Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria

Affiliations

¹ Section of Experimental Haematology, St James's University Hospital, Leeds, United Kingdom.
² Department of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands.
³ Department of Clinical Haematology and BMT Service, The Royal Melbourne Hospital, Melbourne, Australia.
⁴ Department of Haematology, St James' Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom.
⁵ Institute of Transfusion Medicine, University of Ulm, Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen, and University Hospital Ulm, Ulm, Germany.
⁶ King's College Hospital, Hill, Denmark, London, United Kingdom.
⁷ Dipartimento Di Medicina Clinica E Chirurgia Dell' Università Degli Studi Di Napoli Federico II, Napoli, Italy.
⁸ Hematology Department, Cliniques Universitaires UCL Saint-Luc, Brussels, Belgium.
⁹ Hematology Department, University Hospital of Umea, Umea, Sweden.
¹⁰ New England Cancer Specialists, Scarborough, Maine.
¹¹ Alexion Pharmaceuticals, Inc, Cheshire, Connecticut.
¹² AP-HP Hematology Hospital Saint Louis, Paris, France.

PMID: 26690023
DOI: 10.1002/ajh.24280

Free article

Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria

Peter Hillmen et al. Am J Hematol. 2016 Mar.

Free article

. 2016 Mar;91(3):E16-7.

doi: 10.1002/ajh.24280.

Authors

Affiliations

¹ Section of Experimental Haematology, St James's University Hospital, Leeds, United Kingdom.
² Department of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands.
³ Department of Clinical Haematology and BMT Service, The Royal Melbourne Hospital, Melbourne, Australia.
⁴ Department of Haematology, St James' Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom.
⁵ Institute of Transfusion Medicine, University of Ulm, Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen, and University Hospital Ulm, Ulm, Germany.
⁶ King's College Hospital, Hill, Denmark, London, United Kingdom.
⁷ Dipartimento Di Medicina Clinica E Chirurgia Dell' Università Degli Studi Di Napoli Federico II, Napoli, Italy.
⁸ Hematology Department, Cliniques Universitaires UCL Saint-Luc, Brussels, Belgium.
⁹ Hematology Department, University Hospital of Umea, Umea, Sweden.
¹⁰ New England Cancer Specialists, Scarborough, Maine.
¹¹ Alexion Pharmaceuticals, Inc, Cheshire, Connecticut.
¹² AP-HP Hematology Hospital Saint Louis, Paris, France.

PMID: 26690023
DOI: 10.1002/ajh.24280

No abstract available

PubMed Disclaimer

Cited by

New milestones ahead in complement-targeted therapy.
Ricklin D, Lambris JD. Ricklin D, et al. Semin Immunol. 2016 Jun;28(3):208-22. doi: 10.1016/j.smim.2016.06.001. Epub 2016 Jun 16. Semin Immunol. 2016. PMID: 27321574 Free PMC article. Review.
Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Generalized Myasthenia Gravis.
Monteleone JPR, Gao X, Kleijn HJ, Bellanti F, Pelto R. Monteleone JPR, et al. Front Neurol. 2021 Nov 2;12:696385. doi: 10.3389/fneur.2021.696385. eCollection 2021. Front Neurol. 2021. PMID: 34795626 Free PMC article.
Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab.
Wijnsma KL, Ter Heine R, Moes DJAR, Langemeijer S, Schols SEM, Volokhina EB, van den Heuvel LP, Wetzels JFM, van de Kar NCAJ, Brüggemann RJ. Wijnsma KL, et al. Clin Pharmacokinet. 2019 Jul;58(7):859-874. doi: 10.1007/s40262-019-00742-8. Clin Pharmacokinet. 2019. PMID: 30758736 Free PMC article. Review.
Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience.
Goren Sahin D, Akay OM, Keklik M, Okan V, Karakus A, Demir C, Erkurt MA, Ilkkilic K, Yildirim R, Akgun Cagliyan G, Aksu S, Dogu MH, Dal MS, Karakus V, Gemici AI, Terzi H, Kelkitli E, Sivgin S, Unal A, Yilmaz M, Ayyildiz O, Korkmaz S, Eser B, Altuntas F. Goren Sahin D, et al. Ann Hematol. 2021 Jul;100(7):1667-1675. doi: 10.1007/s00277-021-04554-4. Epub 2021 May 14. Ann Hematol. 2021. PMID: 33988739
Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum Disorder.
Singh P, Gao X, Kleijn HJ, Bellanti F, Pelto R. Singh P, et al. Front Neurol. 2021 Nov 3;12:696387. doi: 10.3389/fneur.2021.696387. eCollection 2021. Front Neurol. 2021. PMID: 34803867 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria

Affiliations

Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria

Authors

Affiliations

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources